Bone Health Monitoring in Astronauts: Recommended Use of Quantitative Computed Tomography [QCT] for Clinical and Operational Decisions by Sibonga, J. D. & Truskowski, P.
Bone Health Monitoring in Astronauts: 
Recommended Use of Quantitative 
Computed Tomography [QCT] for Clinical and 
Operational Decisions
J.D. Sibonga and P. Truskowski
On behalf of the NASA Bone Summit Panel for 
Early Onset Osteoporosis in Long-Duration Astronauts.
June 7-8,  2010
Houston, TX
https://ntrs.nasa.gov/search.jsp?R=20110008337 2019-08-30T14:58:47+00:00Z
BASIS FOR BONE SUMMIT
Does spaceflight induce enduring changes
to bone that combine with age-related losses? 
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Risk: Do age-related fractures occur prematurely due to 
previous exposure to long-duration spaceflight.
Cooper and Melton, 1992
Slide courtesy of Amin; adapted
To-date, subclinical effect, but T-scores are inappropriate 
and  not informative for long-duration astronauts 
Clinical Significance: Impact of Age-related Hip 
Fractures
• 50% of survivors post-hip fracture require institutional 
care or functional assistance 
• Decreased quality of life and negative health outcomes 
for men and women with vertebral deformity Poor Osteoporosis 
Intl. 1995; Matthis Osteoporosis Intl. 1998; Scane Osteoporosis Intl. 1999 
MEN TEND TO DO WORSE
• Twice as likely to die in hospital following hip fracture 
than women 
• 1 year mortality rate following hip fracture is higher 
compared with women (31-35% vs. 17-22%) Myers, Am J Epi
1991, Schurch JBMR 1996, Forsen Osteoporosis Intl. 1999, Kiebzak Arch Int Med 2002
Slide adapted from S. Amin, MD.
JSC Human System Risk Forum 11/08
Notably, spaceflight-induced skeletal changes could 
also impact fracture risk after return to earth if 
recovery of bone strength is not sufficiently 
established.
 In the post-mission period when the LD astronaut 
returns to preflight level of physical activity
 In the aging astronaut before or concurrent with age-
related bone loss.*
* age-related bone loss is sex-specific (see figure) with females losing bone mass earlier 
with the onset of menopause.
Given the following, it becomes more critical to reduce the 
uncertainty with how bone mass and bone structure change due 
to spaceflight and with recovery on earth after a mission.
“An asymptomatic systemic bone disease characterized by low bone mass and 
microarchitectural deterioration of bone tissue, with a consequent 
increase in bone fragility and susceptibility of fracture”
Am J Med 1993; Consensus Development Conference: diagnosis, prophylaxis and treatment of 
osteoporosis
“Bone strength reflects the integration of two main features:  bone density 
and bone quality.”
JAMA, 2001
“….Bone quality, in turn, is stated to refer to architecture, turnover, damage 
accumulation, (e.g., microfractures) and mineralization….”
Osteoporosis Intl.  2002
“Bone Quality: What is it and Can we measure it?”
Focused ASBMR- NIH Forum, May 2005
“Structural determinants of vertebral fracture risk.”
Melton et al. J  Bone Mineral Research, 2007  
But,  how does Space Medicine use emerging research 
technologies and data in clinical practice? 
Action to convene a panel of clinical experts for a Bone Summit on 
Early Onset Osteoporosis in Long-Duration Astronauts.
Bone Summit Panel will be asked to:
 Consider the Cohort: Long-duration Astronauts- not the typical 
target population for evaluating osteoporosis or for determining 
age-related fracture risk.
 Understand the Constraints: NASA has a limited and insufficient 
dataset to describe the multi-factorial effects of prolonged 
spaceflight (small n, limited technologies, restricted data collection).
 Recommend a Therapeutic Course of Action:  Panelists need to be 
leaders in the field of bone, knowledgeable in densitometry data 
and bone loss risk factors
 Recommend Approaches for Occupational Risk Surveillance: what 
should NASA do now to address an occupational health risk that 
may manifest later?  
Bone Summit Panel Members
• Eric Orwoll, MD
– Endocrinology and Male Osteoporosis
• E. Michael Lewiecki, MD, FACP, FACE
– Endocrinology, ISCD 
• Neil Binkley, MD, CCD
– ISCD, Geriatrics and Vitamin D
• Shreyasee Amin, MD
– Rheumatology, Male Osteoporosis and 
Epidemiology
• Sue Shapses, PhD
– Nutritional Sciences and Weight-loss
• Robert A. Adler, MD
– Male Osteoporosis and Epidemiology
• Steven Petak, MD, JD, FACE
– Endocrinology, ISCD (contracted by        )
• Mehrsheed Sinaki, MD
– Physical Medicine & Rehabilitation
• Nelson B. Watts, MD
– Endocrinology, ISCD
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Summit Format  and Charge to Panel* 
Individual “charts” of operational & medical data were compiled from 
a subset of LD-astronauts representing novel scenarios or skeletal 
responses (females, repeat fliers, ARED users, with QCT data, with 
bone strength data, with > 10% loss in hip or spine).  Following this 
critical review, the panel was asked to address the following charge:
 Can a clinical trigger be identified, from the evidence-to-date. that 
would require medical response and/or a possible intervention to 
prevent early onset osteoporosis? 
 For occupational risk surveillance, recommend skeletal measures 
for monitoring the risk for premature age-related fractures in this 
population.
* Abbreviated for the theme of this IAA presentation
DATA BACKGROUND
Flight and Earth-based Population Studies
DXA BMD Summary
Rapid (1-1.5%/mo) and 
site-specific BMD loss  
(local not metabolic).
Total BMD loss over 6 mo mission > 2 y loss in sex- and age-
matched population on earth
Loss is variable. 
Recovery is variable.
Recovery is 
prolonged.
Indicates: Multiple 
Risk Factors at play.
QCT measures loss vBMD in trabecular bone compartment 
which DXA technology cannot (n=16 ISS)
Index 
DXA 
 
%/Month 
Change + SD 
Index 
QCT 
%/Month 
Change + SD  
aBMD Lumbar 
Spine 
1.06+0.63* Integral vBMD 
Lumbar Spine 
 
0.9+0.5 
 
 
 
  Trabecular 
vBMD Lumbar 
Spine 
 
0.7+0.6 
aBMD Femoral 
Neck 
1.15+0.84* Integral vBMD 
Femoral Neck 
 
1.2+0.7 
  Trabecular 
vBMD 
Femoral 
 Neck 
 
2.7+1.9 
aBMD 
Trochanter 
1.56+0.99* Integral vBMD 
Trochanter 
 
1.5+0.9 
*p<0.01,  
n=16-18 
 Trabecular 
vBMD 
Trochanter 
2.2+0.9 
 
LeBlanc, J M Neuron Interact, 2000; 
Lang , J Bone Miner Res, 2004; 
Vico, The Lancet 2000
NOT detectable by DXA
QCT in Population Study and in Astronauts
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Suggests that femoral neck total area increases by outward 
displacement when cortex thins with aging– risk of space effects 
combining with aging effects. 
Postmenopausal women
Premenopausal women
**
Riggs et al. JBMR19:1945, 2004.
Lang et al, JBMR, 2006
QCT Extension Study (n=8) Postflight Trabecular BMD in hip.  Carpenter, D et 
al. Acta Astronautica, 2010.
QCT:  Trabecular BMD at hip does not appear 
to show a recovery 2-4 years postflight.
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What is the impact of Trabecular Bone Loss 
on whole hip bone strength? 
Results:  Lower trabecular BMD is an independent 
predictor of hip fracture in elderly men.  
Overall, QCT measures provide useful information 
regarding causation of hip fracture, evaluation of hip 
fracture risk and possible targets for intervention.
EXPERT PANEL 
RECOMMENDATIONS
Panel reviewed 
Recommended Clinical Trigger in Astronauts
• Recommended Postflight Clinical Trigger:  lack of recovery in 
trabecular compartment of hip at R+ 2 years (regardless of 
DXA T-score).  Astronaut/flight doc seeks consult with 
endocrinologist  (Petak) for evaluation and possible 
recommendation for intervention
• Rationale:  Concern for irreversible deficits to this bone 
compartment – an independent fracture predictor.
QCT scans for Occupational Risk Surveillance
NASA’s constraints may be the circumstances in which “research 
technologies should be transition to clinical realm.” 
 Required to detect clinical trigger and for Countermeasure 
Evaluation:  clinical trigger based upon trabecular bone 
compartment – not detectable by DXA but by QCT
 QCT’s additional measures reduce the uncertainty for 
fracture risk and for countermeasure efficacy
 Added benefits: facilitates individualized estimations of bone 
strength by Finite Element Modeling (preliminary findings 
exist in flight evidence base).  Can inform rehabilitation 
approaches.
Images courtesy of Dr. Keyak
Why Apply Finite Element Modeling [FEM] to QCT 
data (a computational tool for complex structures) to 
assess failure loads of whole hip bone.
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Individualized
Fracture Risk
FEM may provide single best composite number to 
estimate bone strength because it integrates multiple 
factors.
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Astronaut data: surrogates of bone strength do not 
correlate suggesting that FEM can detect changes due 
to space that DXA surrogate cannot. 
Slide courtesy of J Keyak; Bone. 2009 Mar;44(3):449-53.
Is DXA T-scorea above -1?
Accept into Corps Ineligible for Corps
no
possible
no
yes
yes
Is L1-1y DXA T-
score above -1.5?
No pre-flight 
intervention 
required
Endocrine Evaluation 
for possible Tx.
yes
Is R1+0y DXA T-score 
above -2?
Is R1+0.5y DXA T-score 
within 2% of preflight?
Is R1+1.0y DXA T-score 
within 2% of preflight?
Is R1+2y DXA T-score within 
2% of preflight?
Conduct R1+3y DXA
yes
no
no
no
Conduct routine DXA every 3 
years from date of DXA 
indicating recovery within 2%          
of preflight  
Is R1+0y DXA T-score within 
2% of preflight?
no
Does R1+2y QCT* indicate 
trabecular bone recovery 
and/or FE strength?
+
yes
yes
yes
yes
yes
R1+1y QCT*: FE strength 
and trabecular recovery
R1+0y QCT*: FE strength 
and trabecular recovery
Send to Dr. Petak
no
L1-(3-12) mo. QCT*: FE 
strength and trabecular 
recovery
Is QCT derived FE strength  
above (TBD)?
Send to Dr. Petak
no
Flight 1
CANDIDATE SELECTION 
TO ASTRONAUT CORPS
PRE-FLIGHT 1
POST-FLIGHT 1
Is QCT-1y derived FE strength at 
time of recertification above 
(TBD)?
yes no
Certified for second 
flight 
Not certified for 
second flight
no
Is L2-1y DXA T-score 
above -1.5?
No pre-flight 
intervention 
required
Consult Dr. Petak
yes
Use of QCT Technology for 
Clinical and Operational Decisions
Flight 2
PRE-FLIGHT 2
POST-FLIGHT 2
no
•All designated QCT scans are for occupational surveillance purposes.  
•a: Total Hip, Femoral Neck, Trochanter
Recommendations from an Expert Panel 
for Consideration by NASA
watch & monitor
watch & monitor
Is R1+0y DXA T-score 
above -2?
Is R1+0.5y DXA T-score 
within 2% of preflight?
Is R1+1.0y DXA T-score 
within 2% of preflight?
Is R1+2y DXA T-score within 
2% of preflight?
Conduct R1+3y DXA
yes
no
no
no
Conduct routine DXA every 3 
years from date of DXA 
indicating recovery within 2%          
of preflight  
Is R1+0y DXA T-score within 
2% of preflight?
no
Does R1+2y QCT* indicate 
trabecular bone recovery 
and/or FE strength ? 
+
yes
yes
yes
yes
yes
R1+1y QCT*: FE strength 
and trabecular recovery
R1+0y QCT*: FE strength 
and trabecular recovery
Send to Dr. Petak
no
Send to Dr. Petak
?+
Additional clinical info ? 
watch & monitor
watch & monitor
no
Discussion
• NASA has a responsibility for the health of astronauts.
• QCT Surveillance will enable the collection of scientific 
knowledge, especially for measures that have been 
validated in population studies.
• QCT will increase the evaluation of bone changes due 
to space and with aging to address risks for current and 
future missions and risks to long-term health.
• Criticality to reduce uncertainty: Federal Employee 
Workman’s Compensation requires a 3-5 year window 
to establish causality between occupational hazard and 
injury or disease.
Concluding Comments
How much uncertainty is acceptable to manage the skeletal 
risks for early onset osteoporosis and for bone fracture? 
Increased understanding of spaceflight effects on bone by 
the Space Life Sciences Directorate:
Will better inform decision-making (both clinical and 
operational),
Will help direct focused and efficient countermeasure 
research and validation,
Will improve the delineation of spaceflight causality 
substantiating occupational risk or injury,
May lead to the translation of research technologies to 
earth-based medicine.
